About Hikal Ltd 
Hikal Ltd
Small Cap
Pharmaceuticals & Biotechnology
Hikal Limited, incorporated on July 8, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals. The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Company has 5 manufacturing facilities across three states in India.
Company Coordinates 
Company Details
717/718 Maker Chamber V, 7th Floor Nariman Point Mumbai Maharashtra : 400021
Registrar Details
Mondkar Computers Pvt Ltd , 21 Shakil Niwas , Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E), Mumbai
Capital Structure 
Present Equity Capital
INR 24.66 Cr
Number of Shares
12.33 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
22-Jun-2018
12.33
24.66
41100250
2
Bonus
27-Feb-2015
8.22
16.44
65760400
2
Stock Split
27-Feb-2015
8.22
16.44
65760400
2
Stock Split
29-Sep-2008
1.64
16.44
1360000
10
Equity Alloted To FII
29-Sep-2008
1.64
16.44
1360000
10
Equity Alloted To FII
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 8 Schemes (4.09%)
FIIs
Held by 54 FIIs (4.23%)
Promoter with highest holding
Kalyani Investment Company Limited (31.36%)
Highest Public shareholder
Tata Mutual Fund - Tata Small Cap Fund (2.68%)
Individual Investors Holdings
16.66%
Management
Designation
Remuneration
Baba Kalyani
Non-Exec & Non-Independent Dir
10.6 lacs
Jai Hiremath
Executive Chairman
5.09 cr
Sameer Hiremath
Managing Director
4.19 cr
Kannan Unni
Non-Exec. & Independent Dir.
18.6 lacs
Sugandha Hiremath
Non-Exec & Non-Independent Dir
16.6 lacs
Prakash V Mehta
Non-Exec. & Independent Dir.
19.6 lacs
Amit B Kalyani
Non-Exec & Non-Independent Dir
8.6 lacs
Ranjit Shahani
Non-Exec. & Independent Dir.
15.6 lacs
Shivani Bhasin Sachdeva
Non-Exec. & Independent Dir.
11.6 lacs
Rajasekhar Reddy
Company Sec. & Compli. Officer
0
Shrikrishna K. Adivarekar
Independent Director
10.6 lacs
Berjis Minoo Desai
Independent Director
0
V R Kaundinya
Independent Director
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drugs
939.14
59.08%
Crop Protection Products
650.47
40.92%
Bulk Drugs
Bulk Drugs
Crop Protection Products
Crop Protection Products
Revenue and Profits:
Net Sales:
318 Cr
(Quarterly Results - Sep 2025)
Net Profit:
-35 Cr
Pharmaceuticals & Biotechnology
INR 2,999 Cr (Small Cap)
296.00
34
0.55%
0.56
0.85%
2.61






